Press Releases Destiny Pharma plc

Equities

Delayed London S.E. Other stock markets 09:48:02 2024-04-29 am EDT			5-day change	1st Jan Change
17.7 ^GBX	+8.92%		-23.04%	-74.71%

Apr. 25	Norcros sells Johnson Tiles UK; Trifast trading well	AN
Apr. 25	Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024

Destiny Pharma : Interim results for the six months ended 30 June 2023	23-09-20	PU
Destiny Pharma : Business Update	23-06-29	PU
Destiny Pharma's nasal spray project already delivering "more than hoped for"	23-05-02	AQ
Destiny Pharma says XF-73 now "very well positioned" for a partnering programme	23-04-18	AQ
Destiny Pharma upbeat on prospects for C. Difficile treatment	23-04-06	AQ
Destiny Pharma looking to move on to phase III with XF-73 nasal gel	23-03-27	AQ
Destiny Pharma "making real progress"	23-03-08	AQ
Destiny Pharma : Director Disclosure	22-12-02	PU
Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections	22-11-21	AQ
Destiny Pharma PLC 'leads the world' in new approach to preventing hospital infections	22-11-21	EQ
Destiny Pharma : Chair’s Investor Update	22-07-28	PU
Destiny Pharma : 26 July – Publication of new data on NTCD-M3	22-07-26	PU
Destiny Pharma : Publication of new data on NTCD-M3	22-07-26	PU
Destiny Pharma receives award from the Cystic Fibrosis Foundation	22-07-13	AQ
Destiny Pharma announce publication of XF-73 drug synergy data	22-07-07	AQ
Destiny Pharma announces start of a new XF-73 research programme	22-07-06	AQ
Destiny Pharma : Board Changes	22-05-26	PU
Destiny Pharma : 27 April 2022 – Posting of Annual Report and Notice of AGM	22-04-27	PU
Destiny Pharma : Posting of Annual Report and Notice of AGM	22-04-27	PU
Destiny Pharma plc - Audited results for year ended 31 December 2021	22-04-13	AQ

No results for this search